蔡 佳叡

Medicine & Life Sciences

1. recombinant FVIIa 100%
2. Carotid Body 96%
3. Hemothorax 96%
4. Organoids 93%
5. Circulating Neoplastic Cells 88%
6. Leiomyosarcoma 85%
7. Positive-Pressure Respiration 83%
8. Intracranial Hemorrhages 80%
9. Chemoradiotherapy 76%
10. Liver Neoplasms 71%
11. Taiwan 70%
12. Colonic Neoplasms 64%
13. Liquid Biopsy 62%
14. Lung Neoplasms 56%
15. Adenocarcinoma 56%
16. Elderly 48%
17. Delivery of Health Care 43%
18. Hemoglobins 38%
19. Pharmaceutical Preparations 35%
20. Therapeutics 30%
21. Neoplasms 28%
22. Hemostasis 23%
23. Colorectal Neoplasms 21%
24. Ventilator Weaning 18%
25. Baroreflex 16%
26. Blood Vessels 16%
27. Carboplatin 16%
28. Epithelial Cell Adhesion Molecule 14%
29. Treatment Failure 13%
30. Sarcoma 13%
31. Hemophilia A 13%
32. Negative Staining 13%
33. Response Evaluation Criteria in Solid Tumors 13%
34. Biomimetics 12%
35. Karnofsky Performance Status 11%
36. Platelet Count 11%
37. Respiratory Insufficiency 11%
38. Neck 10%
39. Ventilation 10%
40. Critical Care 10%
41. Sexuality 10%
42. Respiration 9%
43. Stroke 9%
44. Blood Platelets 9%
45. Life Expectancy 8%
46. Hospitalization 8%
47. Cell Culture Techniques 7%
48. Pressure 7%
49. Hemorrhage 7%
50. Wounds and Injuries 6%